RAD51C deletion screening identifies a recurrent gross deletion in breast cancer and ovarian cancer families.
Schnurbein G, Hauke J, Wappenschmidt B, Weber-Lassalle N, Engert S, Hellebrand H, Garbes L, Becker A, Neidhardt G, Rhiem K, Meindl A, Schmutzler RK, Hahnen E.
Schnurbein G, et al. Among authors: engert s.
Breast Cancer Res. 2013 Dec 20;15(6):R120. doi: 10.1186/bcr3589.
Breast Cancer Res. 2013.
PMID: 24359560
Free PMC article.